A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack.
Marie VipreyMaïlys GouilletCostanza PuppoAnne TermozClaire Della VecchiaLaurent DerexJulie HaesebaertAnne-Marie SchottMarie PréauPublished in: Patient preference and adherence (2020)
Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.